Back

Multimorbidity and frailty as tools for survival prediction in patients undergoing mitral valve edge-to-edge repair - a perspective from the German health care system

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Does age and sex matter for valvular disease? Intervention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Kerstin Piayda

Justus-Liebig University of Giessen, Giessen (Germany)

7 More presentations in this session

Presentation thumbnail
TAVI in very elderly patients: long-term outcomes in a real-world cohort
Doctor N. Carrabba (Florence, IT)
Abstract Slides Video
Presentation thumbnail
Do women fare better in tricuspid regurgitation? Unveiling the gender advantage in tricuspid valve disease
Mrs R. Hinojar Baydes (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Sex differences in pacemaker implantation, ischemic stroke, and mortality after transcatheter aortic valve implantation: a Danish nationwide study
Ms H. Vistisen (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Sex-based differences after aortic valve surgery for infective endocarditis: a SWEDEHEART study
Doctor L. Bearpark (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Gender differences in clinical profiles, management, and outcomes of valvular heart disease: insights from a nationwide cohort
Ms H. Ma (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Does age and sex matter for valvular disease?

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Prognostic impact of multimorbidity and frailty on 90-day survival in older patients hospitalised for acute heart failure: a prospective study
thumbnail
Congress Presentation
Post-procedural mitral regurgitation as an independent predictor of morbidity and mortality outcomes
thumbnail
Congress Presentation
The impact of age and frailty on mortality risk among patients with first-time myocardial infarction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources